Trial intelligence / Profile preview

Closed-loop Strategy vs MDI in Elderly Adults with Type 2 Diabetes

NCT02490085Phase 2Completed

Sponsor
Montreal Clinical Research Institute
Start
Oct 2015
Primary completion
Sep 2018
Countries
1
01

Overview

Phase 2, randomised, open-label trial in type 2 diabetes mellitus (T2DM), sponsored by Montreal Clinical Research Institute. Primary endpoint: Percentage of time of plasma glucose concentrations spent in the target range at 24 hours. Started Oct 2015; status: completed.

02

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on NCT02490085.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02490085.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call